Lowering	O
the	O
overall	O
charge	O
on	O
TMPyP4	B:C0076211
improves	O
its	O
selectivity	O
for	O
G-	O
quadruplex	I:C1956090
DNA	I:C1956090
.	O

Lowering	O
the	O
overall	O
charge	O
on	O
TMPyP4	O
improves	O
its	O
selectivity	O
for	O
G-	B:C1956090
quadruplex	I:C1956090
DNA	I:C1956090
.	O

Ligands	B:C0023688
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	B:C1511699
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	B:C1517336
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	B:C1517336
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	B:C0013227
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	B:C0003392
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	B:C1956090
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	B:C2826292
-	I:C2826292
related	I:C2826292
biological	O
processes	I:C3714634
.	O

Ligands	O
that	O
stabilize	O
non-canonical	O
DNA	O
structures	I:C1511699
called	O
G-	O
quadruplexes	I:C1517336
(	O
G-	O
quadruplexes	I:C1517336
)	O
might	O
have	O
applications	O
in	O
medicine	O
as	O
anti-cancer	O
agents	I:C0003392
,	O
due	O
to	O
the	O
involvement	O
of	O
GQ	O
DNA	I:C1956090
in	O
a	O
variety	O
of	O
cancer	O
-	I:C2826292
related	I:C2826292
biological	B:C3714634
processes	I:C3714634
.	O

Five	O
derivatives	O
of	O
5,10,15,20	B:C0076211
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	B:C0076211
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	B:C1254351
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	B:C1254351
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	B:C1254351
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	B:C1254351
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	B:C1254351
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	B:C0687133
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	B:C0086418
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	B:C0085187
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	B:C0314659
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	B:C0597717
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	B:C0597717
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	O
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

Five	O
derivatives	O
of	O
5,10,15,20	O
-	I:C0076211
tetrakis	I:C0076211
(	I:C0076211
N	I:C0076211
-	I:C0076211
methyl	I:C0076211
-	I:C0076211
4	I:C0076211
-	I:C0076211
pyridyl	I:C0076211
)	I:C0076211
porphyrin	I:C0076211
(	O
TMPyP4	O
)	O
,	O
where	O
a	O
N	O
-	O
methylpyridyl	O
group	O
was	O
replaced	O
with	O
phenyl	O
(	O
4P3	O
)	O
,	O
4	O
-	O
aminopheny	O
l	O
(	O
PN3M	O
)	O
,	O
4	O
-	O
phenylamidoproline	O
(	O
PL3M	O
)	O
,	O
or	O
4	O
-	O
carboxyphenyl	O
(	O
PC3	O
M	I:C1254351
and	O
P2C2M	O
)	O
were	O
investigated	O
for	O
their	O
interactions	O
with	O
human	O
telomeric	O
DNA	I:C0085187
(	O
Tel22	O
)	O
using	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
(	O
fluorescence	O
resonance	I:C0597717
energy	I:C0597717
transfer	I:C0597717
)	O
assay	O
,	O
and	O
UV	O
-	O
visible	O
and	O
circular	O
dichroism	O
spectroscopies	O
in	O
K	B:C0006353
(+	I:C0006353
)	I:C0006353
buffer	I:C0006353
.	O

The	O
molecules	O
are	O
cationic	B:C0007447
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	O
,	O
PN3M	O
,	O
and	O
PL3M	O
)	O
,	O
2	O
+	O
(	O
PC3	O
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	O
)	O
.	O

The	O
molecules	O
are	O
cationic	O
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	B:C1254351
,	O
PN3M	O
,	O
and	O
PL3M	O
)	O
,	O
2	O
+	O
(	O
PC3	O
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	O
)	O
.	O

The	O
molecules	O
are	O
cationic	O
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	O
,	O
PN3M	B:C1254351
,	O
and	O
PL3M	O
)	O
,	O
2	O
+	O
(	O
PC3	O
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	O
)	O
.	O

The	O
molecules	O
are	O
cationic	O
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	O
,	O
PN3M	O
,	O
and	O
PL3M	B:C1254351
)	O
,	O
2	O
+	O
(	O
PC3	O
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	O
)	O
.	O

The	O
molecules	O
are	O
cationic	O
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	O
,	O
PN3M	O
,	O
and	O
PL3M	O
)	O
,	O
2	O
+	O
(	O
PC3	B:C1254351
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	O
)	O
.	O

The	O
molecules	O
are	O
cationic	O
or	O
zwitterionic	O
with	O
an	O
overall	O
charge	O
of	O
3	O
+	O
(	O
4P3	O
,	O
PN3M	O
,	O
and	O
PL3M	O
)	O
,	O
2	O
+	O
(	O
PC3	O
M	I:C1254351
)	O
or	O
neutral	O
(	O
P2C2M	B:C1254351
)	O
.	O

All	O
porphyrins	B:C0032712
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	B:C1254351
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	B:C0086418
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	B:C0085187
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	B:C0597717
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	B:C0022885
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	B:C1254351
is	O
the	O
most	O
stabilizing	O
ligand	O
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

All	O
porphyrins	O
except	O
P2C2	O
M	I:C1254351
stabilize	O
human	O
telomeric	O
DNA	I:C0085187
in	O
FRET	O
assays	I:C0597717
by	O
∼	O
20	O
°C	O
at	O
5	O
eq	O
CD	O
melting	I:C0022885
experiments	I:C0022885
suggest	O
that	O
4P3	O
is	O
the	O
most	O
stabilizing	O
ligand	B:C0023688
with	O
a	O
stabilization	O
temperature	O
of	O
16.8	O
°C	O
at	O
4	O
eq	O
.	O

Importantly	O
,	O
4P3	B:C1254351
,	O
PC3M	O
and	O
PL3M	O
demonstrate	O
excellent	O
selectivity	O
for	O
quadruplexes	O
,	O
far	O
superior	O
to	O
that	O
of	O
TMPyP4	O
.	O

Importantly	O
,	O
4P3	O
,	O
PC3M	B:C1254351
and	O
PL3M	O
demonstrate	O
excellent	O
selectivity	O
for	O
quadruplexes	O
,	O
far	O
superior	O
to	O
that	O
of	O
TMPyP4	O
.	O

Importantly	O
,	O
4P3	O
,	O
PC3M	O
and	O
PL3M	B:C1254351
demonstrate	O
excellent	O
selectivity	O
for	O
quadruplexes	O
,	O
far	O
superior	O
to	O
that	O
of	O
TMPyP4	O
.	O

Importantly	O
,	O
4P3	O
,	O
PC3M	O
and	O
PL3M	O
demonstrate	O
excellent	O
selectivity	O
for	O
quadruplexes	B:C1956090
,	O
far	O
superior	O
to	O
that	O
of	O
TMPyP4	O
.	O

Importantly	O
,	O
4P3	O
,	O
PC3M	O
and	O
PL3M	O
demonstrate	O
excellent	O
selectivity	O
for	O
quadruplexes	O
,	O
far	O
superior	O
to	O
that	O
of	O
TMPyP4	B:C0076211
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	B:C0022885
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	B:C1254351
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	B:C1254351
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	B:C1254351
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	B:C1254351
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	B:C1254351
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	O
.	O

Binding	O
constants	O
,	O
determined	O
using	O
UV	O
-	I:C0022885
vis	I:C0022885
titrations	I:C0022885
,	O
correlate	O
with	O
charge	O
:	O
triply	O
cationic	I:C1254351
4P3	I:C1254351
,	O
PN3M	O
and	O
PL3M	O
display	O
Ka	O
of	O
5	O
-	O
9	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
doubly	O
cationic	I:C1254351
PC3M	I:C1254351
displays	O
Ka	O
of	O
1	O
μ	O
M	O
(	O
-	O
1	O
)	O
,	O
and	O
neutral	O
P2C2	O
M	I:C1254351
displays	O
weak	O
-	O
to	O
-	O
no	O
binding	B:C1148673
.	O

UV	O
-	O
vis	O
data	O
suggest	O
that	O
binding	B:C1148673
interactions	I:C1148673
are	O
driven	O
by	O
electrostatic	O
attractions	O
and	O
that	O
the	O
binding	O
mode	O
may	O
be	O
base	O
-	O
stacking	O
(	O
or	O
end	O
-	O
stacking	O
)	O
judging	O
by	O
the	O
high	O
values	O
of	O
red	O
shift	O
(	O
15	O
-	O
20	O
nm	O
)	O
and	O
hypochromicity	O
(	O
40	O
-	O
50	O
%	O
)	O
.	O

UV	O
-	O
vis	O
data	O
suggest	O
that	O
binding	O
interactions	I:C1148673
are	O
driven	O
by	O
electrostatic	O
attractions	O
and	O
that	O
the	O
binding	B:C1148673
mode	O
may	O
be	O
base	O
-	O
stacking	O
(	O
or	O
end	O
-	O
stacking	O
)	O
judging	O
by	O
the	O
high	O
values	O
of	O
red	O
shift	O
(	O
15	O
-	O
20	O
nm	O
)	O
and	O
hypochromicity	O
(	O
40	O
-	O
50	O
%	O
)	O
.	O

We	O
conclude	O
that	O
lowering	O
the	O
charge	O
on	O
TMPyP4	B:C0076211
to	O
3	O
+	O
can	O
achieve	O
the	O
desired	O
balance	O
between	O
stabilizing	O
ability	O
,	O
affinity	O
,	O
and	O
high	O
selectivity	O
required	O
for	O
an	O
excellent	O
quadruplex	O
ligand	O
.	O

We	O
conclude	O
that	O
lowering	O
the	O
charge	O
on	O
TMPyP4	O
to	O
3	O
+	O
can	O
achieve	O
the	O
desired	O
balance	O
between	O
stabilizing	O
ability	O
,	O
affinity	O
,	O
and	O
high	O
selectivity	O
required	O
for	O
an	O
excellent	O
quadruplex	B:C1956090
ligand	O
.	O

We	O
conclude	O
that	O
lowering	O
the	O
charge	O
on	O
TMPyP4	O
to	O
3	O
+	O
can	O
achieve	O
the	O
desired	O
balance	O
between	O
stabilizing	O
ability	O
,	O
affinity	O
,	O
and	O
high	O
selectivity	O
required	O
for	O
an	O
excellent	O
quadruplex	O
ligand	B:C0023688
.	O

